Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.49
-0.15 (-1.29%)
At close: Aug 1, 2025, 4:00 PM
11.47
-0.02 (-0.17%)
After-hours: Aug 1, 2025, 7:56 PM EDT

Intellia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1,1901,1882,7312,9748,7993,514
Upgrade
Market Cap Growth
-72.16%-56.51%-8.18%-66.20%150.41%390.02%
Upgrade
Enterprise Value
6023441,8562,2237,7273,128
Upgrade
Last Close Price
11.4911.6630.4934.89118.2454.40
Upgrade
PS Ratio
25.4320.5275.2757.06266.2260.59
Upgrade
PB Ratio
1.531.362.602.418.466.67
Upgrade
P/TBV Ratio
1.531.362.602.418.466.67
Upgrade
EV/Sales Ratio
13.225.9551.1742.65233.7653.94
Upgrade
Debt / Equity Ratio
0.150.240.110.110.070.08
Upgrade
Asset Turnover
0.040.050.030.040.030.12
Upgrade
Quick Ratio
4.575.508.239.455.979.33
Upgrade
Current Ratio
4.905.778.669.626.119.60
Upgrade
Return on Equity (ROE)
-57.92%-54.01%-42.10%-41.67%-34.19%-33.69%
Upgrade
Return on Assets (ROA)
-30.12%-26.80%-22.83%-20.35%-16.99%-16.89%
Upgrade
Return on Capital (ROIC)
-33.05%-29.71%-25.44%-23.09%-19.92%-19.98%
Upgrade
Earnings Yield
-44.19%-43.70%-17.62%-15.95%-3.04%-3.82%
Upgrade
FCF Yield
-32.03%-29.87%-14.95%-11.66%-2.70%-1.52%
Upgrade
Buyback Yield / Dilution
-11.19%-11.35%-15.33%-8.57%-26.63%-18.50%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q